Patent intelligence · US
US 7192546
Methods of forming shaped articles from suspensions
Methods of forming shaped articles from suspensions
Patent details — US 7192546
- Jurisdiction
- US
- Status
- granted
- Grant date
- Mar 20, 2007
- Expiration
- Mar 15, 2027
- Applicant
- Albright & Wilson (Australia) Limited
- Claims
- 14
- CPC classes
- A61K, A61K9/1652, A61K9/1694, A61K9/205
Quick answer
US 7192546 (Methods of forming shaped articles from suspensions) is held by Albright & Wilson (Australia) Limited. Status: granted. Granted Mar 20, 2007. Expires Mar 15, 2027 (1 year remaining) — relevant for patent-cliff and LOE planning.
Key facts
- Applicant
- Albright & Wilson (Australia) Limited
- Grant date
- Expiration
- Claims
- 14
- CPC classes
- A61K, A61K9/1652, A61K9/1694, A61K9/205, A61K9/2095
More from Albright & Wilson (Australia) Limited
Related pharmaceutical patents in our USPTO index.
-
US 12383631
Immune antigen specific IL-18 immunocytokines and uses thereof
granted -
US 12350120
Gum-protecting and teeth-whitening strip and preparation method thereof
granted -
US 12220447
Proteolytic enzyme composition
granted -
US 12215133
GIP and GLP-1 dual receptor agonist, pharmaceutical composition, and use
granted -
US 12173062
Modified TNF-α antibodies and uses thereof
granted -
US 12115136
Fortified CBD oil for treatment of PTSD
granted -
US 12097230
Method and composition for treating post operative conditions
granted -
US 11925686
Materials for phototherapies of ophthalmic diseases
granted
Frequently asked questions
What is US patent 7192546?
US 7192546 (Methods of forming shaped articles from suspensions) is held by Albright & Wilson (Australia) Limited. Status: granted. Granted Mar 20, 2007. Expires Mar 15, 2027 (1 year remaining) — relevant for patent-cliff and LOE planning.
Who owns US 7192546?
Albright & Wilson (Australia) Limited is listed as the applicant in USPTO PatentsView records indexed by NovaPharmaNews. We track 57 pharmaceutical patents for this assignee.
When does US 7192546 expire?
Our index shows an expiration date of Mar 15, 2027 (1 year from today). Confirm material dates against USPTO, FDA Orange Book, or qualified counsel before contractual decisions.